These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 35504491)
1. Cytomegalovirus variation among newborns treated with valganciclovir. Dobbins GC; Kimberlin DW; Ross SA Antiviral Res; 2022 Jul; 203():105326. PubMed ID: 35504491 [TBL] [Abstract][Full Text] [Related]
2. Onset of valganciclovir resistance in two infants with congenital cytomegalovirus infection. Garofoli F; Lombardi G; Angelini M; Campanini G; Zavattoni M; Baldanti F Int J Infect Dis; 2020 Sep; 98():150-152. PubMed ID: 32615325 [TBL] [Abstract][Full Text] [Related]
3. Viral load in children with congenital cytomegalovirus infection identified on newborn hearing screening. Kawada J; Torii Y; Kawano Y; Suzuki M; Kamiya Y; Kotani T; Kikkawa F; Kimura H; Ito Y J Clin Virol; 2015 Apr; 65():41-5. PubMed ID: 25766986 [TBL] [Abstract][Full Text] [Related]
4. Hearing outcomes in children with congenital cytomegalovirus infection: From management controversies to lack of parents' knowledge. Aldè M; Caputo E; Di Berardino F; Ambrosetti U; Barozzi S; Piatti G; Zanetti D; Pignataro L; Cantarella G Int J Pediatr Otorhinolaryngol; 2023 Jan; 164():111420. PubMed ID: 36563581 [TBL] [Abstract][Full Text] [Related]
5. Genotypic diversity and mixed infection in newborn disease and hearing loss in congenital cytomegalovirus infection. Pati SK; Pinninti S; Novak Z; Chowdhury N; Patro RK; Fowler K; Ross S; Boppana S; Pediatr Infect Dis J; 2013 Oct; 32(10):1050-4. PubMed ID: 23694837 [TBL] [Abstract][Full Text] [Related]
6. Emergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection. Choi KY; Sharon B; Balfour HH; Belani K; Pozos TC; Schleiss MR J Clin Virol; 2013 Aug; 57(4):356-60. PubMed ID: 23688863 [TBL] [Abstract][Full Text] [Related]
7. Effect on hearing of oral valganciclovir for asymptomatic congenital cytomegalovirus infection. Yilmaz Çiftdogan D; Vardar F J Trop Pediatr; 2011 Apr; 57(2):132-4. PubMed ID: 20576693 [TBL] [Abstract][Full Text] [Related]
8. Valganciclovir Is Beneficial in Children with Congenital Cytomegalovirus and Isolated Hearing Loss. Pasternak Y; Ziv L; Attias J; Amir J; Bilavsky E J Pediatr; 2018 Aug; 199():166-170. PubMed ID: 29605391 [TBL] [Abstract][Full Text] [Related]
9. Treatment of congenital cytomegalovirus beyond the neonatal period: an observational study. Dorfman L; Amir J; Attias J; Bilavsky E Eur J Pediatr; 2020 May; 179(5):807-812. PubMed ID: 31927626 [TBL] [Abstract][Full Text] [Related]
10. "Minimally symptomatic" congenital cytomegalovirus infection: latest data and emerging concepts. Howard A; Nishikawa JK; Sánchez PJ Curr Opin Pediatr; 2024 Aug; 36(4):480-488. PubMed ID: 38747205 [TBL] [Abstract][Full Text] [Related]
11. Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss. Williams EJ; Kadambari S; Berrington JE; Luck S; Atkinson C; Walter S; Embleton ND; James P; Griffiths P; Davis A; Sharland M; Clark JE Arch Dis Child Fetal Neonatal Ed; 2014 May; 99(3):F230-6. PubMed ID: 24596404 [TBL] [Abstract][Full Text] [Related]
12. Clinical outcome and the role of antivirals in congenital cytomegalovirus infection. Ross SA; Kimberlin D Antiviral Res; 2021 Jul; 191():105083. PubMed ID: 33964331 [TBL] [Abstract][Full Text] [Related]
13. Valganciclovir in Infants with Hearing Loss and Clinically Inapparent Congenital Cytomegalovirus Infection: A Nonrandomized Controlled Trial. Chung PK; Schornagel FAJ; Soede W; van Zwet EW; Kroes ACM; Oudesluys-Murphy AM; Vossen ACTM J Pediatr; 2024 May; 268():113945. PubMed ID: 38336204 [TBL] [Abstract][Full Text] [Related]
14. Association of CMV genomic mutations with symptomatic infection and hearing loss in congenital CMV infection. Dobbins GC; Patki A; Chen D; Tiwari HK; Hendrickson C; Britt WJ; Fowler K; Chen JY; Boppana SB; Ross SA BMC Infect Dis; 2019 Dec; 19(1):1046. PubMed ID: 31822287 [TBL] [Abstract][Full Text] [Related]
15. A cohort study of the universal neonatal urine screening for congenital cytomegalovirus infection. Yamada H; Tanimura K; Fukushima S; Fujioka K; Deguchi M; Sasagawa Y; Tairaku S; Funakoshi T; Morioka I J Infect Chemother; 2020 Aug; 26(8):790-794. PubMed ID: 32273174 [TBL] [Abstract][Full Text] [Related]
16. 10-year follow-up of congenital cytomegalovirus infection complicated with severe neurological findings in infancy: a case report. Suganuma E; Oka A; Sakata H; Adachi N; Asanuma S; Oguma E; Yamaguchi A; Furuichi M; Uejima Y; Sato S; Takano T; Kawano Y; Tanaka R; Arai T; Oh-Ishi T BMC Pediatr; 2018 Nov; 18(1):369. PubMed ID: 30470211 [TBL] [Abstract][Full Text] [Related]
17. Long-term hearing outcomes of children with symptomatic congenital CMV treated with valganciclovir. McCrary H; Sheng X; Greene T; Park A Int J Pediatr Otorhinolaryngol; 2019 Mar; 118():124-127. PubMed ID: 30611098 [TBL] [Abstract][Full Text] [Related]
18. Congenital cytomegalovirus: what the otolaryngologist should know. Duval M; Park AH Curr Opin Otolaryngol Head Neck Surg; 2014 Dec; 22(6):495-500. PubMed ID: 25222916 [TBL] [Abstract][Full Text] [Related]
19. Oral Valganciclovir Initiated Beyond 1 Month of Age as Treatment of Sensorineural Hearing Loss Caused by Congenital Cytomegalovirus Infection: A Randomized Clinical Trial. Kimberlin DW; Aban I; Peri K; Nishikawa JK; Bernatoniene J; Emonts M; Klein N; Bamford A; DeBiasi RL; Faust SN; Jones CE; McMaster P; Caserta M; Ahmed A; Sharland M; Demmler-Harrison G; Hackett S; Sánchez PJ; Shackley F; Kelly D; Dennehy PH; Storch GA; Whitley RJ; Griffiths P; J Pediatr; 2024 May; 268():113934. PubMed ID: 38309519 [TBL] [Abstract][Full Text] [Related]
20. Congenital and Postnatal Cytomegalovirus: Case Series and State of the Science for Neonatal Providers. Salemi TF; McLean VR; Jnah AJ Neonatal Netw; 2024 Apr; 43(2):92-104. PubMed ID: 38599771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]